The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant gain of 39.70% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 436.05%. Over the past 30 days, the price of TOI has fallen by 48.71%. And in the last five days, it has fallen by -6.68%.
The current stock price for Oncology Institute Inc (TOI) is $2.31. The stock experienced a significant increase during the last trading session, reaching $2.3499 after opening at $2.02. It dipped to a low of $1.95 before ultimately closing at $2.06.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Oncology Institute Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $2.65 on 11/13/23, and the lowest price during the same period was recorded at $0.33 on 06/05/23.
52-week price history of TOI Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Oncology Institute Inc’s current trading price is -13.18% away from its 52-week high, while its distance from the 52-week low is 598.48%. The stock’s price range over this timeframe has been between $0.33 and $2.65. The shares of the Healthcare sector company recorded a trading volume of approximately 0.51 million for the day, which was comparatively higher than the average daily volume of 0.22 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Oncology Institute Inc (TOI) has experienced a quarterly rise of 181.85% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 169.99M and boasts a workforce of 750 employees.
Expert Opinions: Analysts’ Ratings for Oncology Institute Inc
As of right now, 1 analyst is rating Oncology Institute Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.29, with a change in price of +1.69. Similarly, Oncology Institute Inc recorded 269,640 in trading volume during the last 100 days, posting a change of +276.33%.
TOI’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for TOI stands at 1.63. Similarly, the long-term debt-to-equity ratio is also 1.55.
TOI Stock Stochastic Average
The raw stochastic average for Oncology Institute Inc over the last 50 days is presently at 74.73%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 70.95%. Further, the company’s Stochastic %K and %D values for the last 20 days were 61.83% and 68.28%, respectively.
